Funding profile · Teledermatology and online pharmacy

Clinikally

An India-incorporated telemedicine and e-pharmacy company with two independently reported rounds totalling $3.1 million and no SEC filings, since it operates and raises entirely within India. Here is what the corporate registry and filed financials show, and where a funding database’s numbers do not check out.

Data as of September 25, 2026. Company-reported figures are labeled.

Rounds at a glance

What the record shows

Clinikally Digital Health Private Limited is incorporated in India, registered with the Registrar of Companies, Delhi, under CIN U52602HR2021PTC096454, and has not filed a Form D or appeared in any other SEC record found in this research. That is expected: it is an Indian operating company raising from a mix of Indian and international investors directly, with no sign of a US or Delaware holding structure. What exists instead of SEC filings is India’s own corporate registry and the financial statements Clinikally has filed with it.

Those filings show authorized share capital of Rs 15 lakh and paid up capital of Rs 7.3 lakh as of the most recent filing, figures that describe the company’s nominal share base rather than the cash it has actually raised from investors, which is reported separately by the press. For the year ending March 31, 2025, Clinikally reported revenue of Rs 31.1 crore, up 84.4 percent from Rs 16.8 crore the year before, a net loss of Rs 89.1 lakh that had narrowed 71 percent from the prior year, an estimated EBITDA of negative Rs 43.1 lakh, and total assets of Rs 14.4 crore, up 46 percent year on year.

Reading the record

1. Two rounds are solid, a third is not.Entrackr and MobiHealthNews, both outlets Clinikally does not pay, independently reported the same $500,000 pre-seed in July 2022 and the same $2.6 million round in September 2023, with matching investor names. A funding database’s claim of $6.6 million across four rounds adds a $3 million round and a duplicate $500,000 round with investor names, including several German language angel names and US funds like Comcast Ventures, that appear nowhere else in connection with this company.
2. The loss is shrinking as revenue scales.Revenue nearly doubled from Rs 16.8 crore to Rs 31.1 crore between FY24 and FY25, while the net loss fell to Rs 89.1 lakh, a net margin of about negative 3 percent. That is a business getting closer to breakeven, not one burning faster as it grows.
3. The founder kept most of the company through 2023.Entrackr reported that as of the September 2023 round, founder and CEO Arjun Soin held more than 90 percent of Clinikally, which means the $3.1 million in disclosed outside funding bought a relatively small minority stake, consistent with the company’s small paid up capital base on record.
4. The company’s capital base is nominal, not a funding record.Clinikally’s authorized capital of Rs 15 lakh and paid up capital of Rs 7.3 lakh reflect the par value of shares issued, not the premium investors actually paid. Reported funding of $3.1 million would sit almost entirely in share premium and reserves, which are not broken out in the summary data available for this research.

Commercial signals

What to watch

• A named, independently reported third funding round that would corroborate the $6.6 million aggregator total.
• FY26 filed financials, for the year ending March 2026, to see whether the narrowing loss reaches breakeven.
• Any move to a US or offshore holding structure, which would put future rounds into SEC Form D territory.
• Disclosure of the drug or pharmacy license the online pharmacy operates under, not found in this research.

The Clinikally story on Healthcare DiscoveryHealthcare Discovery

Related companies

• Aegis: Shared investor: Rebel Fund. A three person Y Combinator startup building AI agents that detect denied health insurance claims, draft the appeal, and file it, aiming to turn a two hour manual task
• DocVita: Shared investor: Goodwater. A WhatsApp led marketplace that matches Indian patients with vetted therapists and psychiatrists, online and in person
• Jeevam Health: Shared investor: Goodwater. A Y Combinator backed app that paired functional medicine doctors with Indian thyroid and autoimmune patients, built on the idea that medication alone was not fixing
• Fitia: Shared investor: Goodwater. A Lima-built AI meal planner and calorie counter that says it has passed 10 million users across the Spanish-speaking world and is now pushing into the United States

Sources

1. Public recordClinikally Digital Health Private Limited company record, CIN U52602HR2021PTC096454Registrationwala · accessed Sep 25, 2026
2. Public recordClinikally Digital Health Private Limited director and DIN detailInsider Biz · accessed Sep 25, 2026
3. Public recordClinikally Digital Health Private Limited company and director summaryTofler · updated Sep 8, 2026
4. Public recordClinikally financial breakdown, FY25 revenue and profit and lossInc42 Datalabs · accessed Sep 25, 2026
5. IndependentClinikally raises $2.6 Mn from Y Combinator, Tribe Capital and othersEntrackr, Gyan Vardhan · Sep 29, 2023
6. IndependentClinikally amasses 1.5 Mn customers within three year of launchEntrackr, Kunal Manchanada · Dec 19, 2024
7. IndependentDerma startup Clinikally bags $2.6M to go omnichannelMobiHealthNews, Adam Ang · Feb 10, 2023
8. AggregatorClinikally: Funding, Team & Investors, including the unverified $6.6M totalStartup Intros · Jul 13, 2026

Compiled from India’s Ministry of Corporate Affairs company registry, independent press reporting and aggregated filed financial data as of September 25, 2026. Clinikally is incorporated in India and has not filed with the US SEC. Healthcare Venture Capital Fund holds no position in Clinikally. This page is not an offer to sell or a recommendation to buy any security.